Syndax Pharmaceuticals Inc (SNDX) Revenue from Contract with Customer, Excluding Assessed Tax USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Syndax Pharmaceuticals Inc quarterly Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from 2016 to 2023.
  • Syndax Pharmaceuticals Inc Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending December 31, 2023 was $0.000.
  • Syndax Pharmaceuticals Inc Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending December 31, 2023 was $0.000.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q4 2022 $0 -$140M -100% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q4 2021 $127M +$126M +33209% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q4 2021 $140M +$138M +9110% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $12.4M +$12M +3165% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $379K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $379K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $380K $0 0% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-12
Q4 2020 $1.52M $0 0% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $379K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $379K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $379K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $380K $0 0% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q4 2019 $1.52M $0 0% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $379K $0 0% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-12
Q2 2019 $379K $0 0% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-12
Q1 2019 $379K $0 0% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-12
Q4 2018 $380K -$813K -68.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q4 2018 $1.52M -$591K -28% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $379K +$74K +24.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-05
Q2 2018 $379K +$74K +24.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-05
Q1 2018 $379K +$74K +24.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-05
Q4 2017 $1.19M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q4 2017 $2.11M +$888K +72.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 $305K Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 $305K Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 $305K Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 $1.22M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.